25.21
price up icon0.80%   0.20
after-market Dopo l'orario di chiusura: 25.12 -0.09 -0.36%
loading

Pfizer Inc Borsa (PFE) Ultime notizie

pulisher
Mar 30, 2025

Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows - Insider Monkey

Mar 30, 2025
pulisher
Mar 29, 2025

Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns - Seeking Alpha

Mar 29, 2025
pulisher
Mar 28, 2025

What Does the Market Think About Pfizer? - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (Rating Upgrade) - Seeking Alpha

Mar 28, 2025
pulisher
Mar 28, 2025

Minoxidil Market Set to Witness Significant Growth by 2025-2032 - openPR

Mar 28, 2025
pulisher
Mar 28, 2025

Pfizer leader who launched Covid vaccine gives small pharma a try - The Business Journals

Mar 28, 2025
pulisher
Mar 28, 2025

Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History” - Markets Insider

Mar 28, 2025
pulisher
Mar 27, 2025

UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection | Newswise - Newswise

Mar 27, 2025
pulisher
Mar 27, 2025

Pfizer: Value Play Or Past Its Prime? - Barchart

Mar 27, 2025
pulisher
Mar 27, 2025

Pfizer: Value Play or Past Its Prime? - The Globe and Mail

Mar 27, 2025
pulisher
Mar 27, 2025

Pfizer Tops Pharma Tax Avoidance, Senate Dems Say - Law360

Mar 27, 2025
pulisher
Mar 27, 2025

US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports - Reuters

Mar 27, 2025
pulisher
Mar 27, 2025

Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

Sector Update: Health Care - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Pfizer's Bold Tax Maneuver Sparks Controversy - Finimize

Mar 27, 2025
pulisher
Mar 27, 2025

Is Pfizer Stock A Sell With A Looming First-Quarter Slowdown? - Investor's Business Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Pfizer Avoided Billions in Taxes on Sales, Democrats Say (2) - Bloomberg Tax

Mar 27, 2025
pulisher
Mar 27, 2025

Living with Colon Cancer: A Pfizer Colleague’s Story - Pfizer

Mar 27, 2025
pulisher
Mar 27, 2025

May 9th Options Now Available For Pfizer (PFE) - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

GSK accuses Pfizer of delaying Covid vaccine result until after US election - Yahoo

Mar 27, 2025
pulisher
Mar 27, 2025

Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Why Pfizer Is My Largest Healthcare Position - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Citi maintains Pfizer stock Neutral with $27 target amid probe By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Citi maintains Pfizer stock Neutral with $27 target amid probe - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report - New York Post

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer Stock Slips After Report on Vaccine Timing Probe - The Wall Street Journal

Mar 26, 2025
pulisher
Mar 26, 2025

Exclusive | U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine - The Wall Street Journal

Mar 26, 2025
pulisher
Mar 26, 2025

Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers - GuruFocus.com

Mar 26, 2025
pulisher
Mar 26, 2025

Here's Why Pfizer (PFE) Fell More Than Broader Market - Yahoo Finance

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer Shares Are Down Today: What's Going On? - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer shares dip amid U.S. vaccine probe reports By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer shares dip amid U.S. vaccine probe reports - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer drops after report on U.S. probe related to its COVID vaccine success - Seeking Alpha

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer falls after report says US probing tip about timing of COVID vaccine - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

US Prosecutors Investigate Tip on Pfizer Vaccine - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

US Prosecutors Investigate Tip on Pfizer Vaccine, Wall Street Journal Reports - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

US Prosecutors Probe Tip About Timing Of Pfizer VaccineWSJ - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Moderna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cuts - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Pfizer’s CX Vision: Powered by People, Fueled by Data - CMSWire

Mar 26, 2025
pulisher
Mar 26, 2025

ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program - Quantisnow

Mar 26, 2025
pulisher
Mar 25, 2025

Drug Co. Wants Fed. Circ. To Undo Pfizer COVID Patent Win - Law360

Mar 25, 2025
pulisher
Mar 25, 2025

Pfizer: Undervalued Defensive Play - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Pfizer Is Trading As If It's 2009 Again (NYSE:PFE) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Which is the Healthiest Investment: Merck or PfizerF.A.S.T. GraphsCommentaries - Advisor Perspectives

Mar 25, 2025
pulisher
Mar 25, 2025

Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day - TradingView

Mar 25, 2025
pulisher
Mar 24, 2025

USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars? - Crowell & Moring LLP

Mar 24, 2025
pulisher
Mar 24, 2025

Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds? - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Pfizer Is A Dirt-Cheap High-Yield Stock, But Is It A Buy? - Barchart

Mar 24, 2025
pulisher
Mar 24, 2025

China touted its business potential at a meeting with Apple, Pfizer and other US companies - Українські Національні Новини

Mar 24, 2025
$111.79
price up icon 0.57%
drug_manufacturers_general SNY
$55.82
price up icon 1.66%
$306.95
price up icon 0.39%
drug_manufacturers_general NVS
$112.57
price up icon 1.05%
drug_manufacturers_general MRK
$89.23
price up icon 1.86%
Capitalizzazione:     |  Volume (24 ore):